UBS Group »

Windtree Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Windtree Therapeutics (WINT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Windtree Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Windtree Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Windtree Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $340 510 0.67
2023-09-30 $5.9k 5.9k 1.00
2023-06-30 $10 9 1.22
2023-03-31 $1.8k 357 5.00